Health ❯ Healthcare ❯ Diabetes

Type 1 Diabetes

Insulin Therapy Type 2 Diabetes Insulin Treatment Teplizumab Immune Modulation Insulin Hyperglycemia Adult Management Insulin Production Clinical Trials Treatment Options Insulin Injections Efsitora Alfa Gene Therapy Solutions Insulin Requirements Insulin Management Misdiagnosis Issues Patient Education Clinical Research Artificial Pancreas Automated Insulin Delivery Pumps Autoimmune Diabetes Pediatric Management Early Diagnosis Type 1 Diabetes Treatment Stage 3 Type 1 Diabetes Insulin Dependence Management Strategies Preclinical Stages Insulin Efsitora Alfa Monitoring Guidelines COVALENT-112 GLP-1 Usage

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

The decision rests on reduced C‑peptide decline seen in the PROTECT trial and global data, and the FDA requires confirmatory studies to prove real clinical benefit.

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

FDA Approves Langlara as Interchangeable Biosimilar to Lantus

Stanford’s Low-Radiation Transplant Combo Reverses Type 1 Diabetes in Mice

CRISPR Therapeutics’ Pipeline Pitched as Path to One-Time Heart Risk Treatments

Biomea Fusion Reports Positive 52-Week Phase II Results for Icovamenib in Diabetes

EU Medicines Panel Backs Teizeild to Delay Type 1 Diabetes Onset

Neil Diamond Receives Carousel Ball Honor, Delivers Rare Sweet Caroline Duet

Tandem Diabetes Announces Urgent Medical Device Correction for t:slim X2 Pumps